Verseau Therapeutics, Inc. — Form D

Verseau Therapeutics, Inc. of Auburndale, MA, a company, filed a Form D exempt-offering notice with the SEC on 2017-03-30. The offering totals $11.4M, of which $4.3M was reported sold. Industry: Other Health Care.

Offering

• Filed: 2017-03-30
• Form: D
• Accession: 0001701272-17-000001
• Industry: Other Health Care
• Exemptions: 06b
• Total offering: $11.4M
• Amount sold: $4.3M
• Remaining: $7.2M
• Investors: 5
• Date of first sale: 2017-03-15
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-283695

Issuer

• Name: Verseau Therapeutics, Inc.
• CIK: 0001701272
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2017
• Address: 2000 Commonwealth Avenue, Auburndale, MA, 02466
• Phone: 617-244-9050

Officers, directors & promoters (9)

More

• CIK 1701272 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search